CXCR4 and acute myeloid leukemia: The first generation of CXCR4 antagonist AMD3100 inhibited the migration of AML blasts induced by SDF‐1 and their proliferation in vitro and reversed the enhanced engraftment of AML blasts into NOD/SCID mice mediated by SDF‐1.55